AT&S Austria Technologie & Systemtechnik AG

  • WKN: 922230
  • ISIN: AT0000969985
  • Land: Österreich

Nachricht vom 26.11.2009 | 07:26

AT&S gives outlook for the full financial year 2009/10 and the following financial year


AT&S Austria Technologie & Systemtechnik AG / Forecast

26.11.2009 

Dissemination of an Ad hoc announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


Guidance for 2009/10 and 2010/11 At today's AT&S Capital Markets Day, the Company gives an outlook for the full financial year 2009/10 as well as on the following financial year. Outlook for the financial year 2009/10, ending at 31 March 2010 - The third quarter will be significantly stronger than the second quarter. - Total revenues for the financial year will amount to approx. EUR 360 million. - EBIT exclusive non-recurring items will be positive. - Investments (CAPEX) will amount to approx. EUR 25 million. Outlook for the financial year 2010/11, ending at 31 March 2011 - As the budgeting process will start in December, it is still too early to state revenues and earnings. - Investments (CAPEX) vary with two scenarios: Szenario 1: The economy dips again. In this case, the Company will focus on generating a positive Free Cash-Flow. Maintenance CAPEX of around EUR 15 million and investments in new technologies of around EUR 10 million have to be assumed under this scenario. Hence, total CAPEX would amount to approx. EUR 25 million. Szenario 2: The economy develops positively, and the trend to more advanced 3-n-3 and 4-n-4 HDI-printed circuit boards continues. In this case, the Company will focus on growth. Maintenance CAPEX of around EUR 15 million, investments in new technologies of around EUR 10 million, investments of up to EUR 40 million to adjust the plant in Shanghai (China) to the more advanced technological demands and investments for the expansion of the second plant in Nanjangud (India) of around EUR 15 million have to be assumed under this scenario. Hence, total CAPEX would amount to approx. EUR 80 million. For further information: AT&S Austria Technologie & Systemtechnik AG Hans Lang, IRO Tel. +43-1-68300-9259, e-mail: h.lang@ats.net, www.ats.net 26.11.2009 Financial News distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: AT&S Austria Technologie & Systemtechnik AG Fabriksgasse 13 8700 Leoben Österreich Phone: +43 (1) 3842200-0 Fax: +43 (1) 3842200-216 E-mail: info@ats.net Internet: www.ats.net ISIN: AT0000969985, AT0000A09S02 WKN: 922230 Listed: Freiverkehr in Berlin, Hannover, München, Hamburg, Düsseldorf, Stuttgart; Open Market in Frankfurt; Foreign Exchange(s) Wien End of News DGAP News-Service

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

Original-Research: Gold Mountain Mining Corp. (von hanseatic stock publishing UG (haftungsbeschränkt)): Gold Mountain Mining Corp.

29. November 2021